Cargando…
Comparative effectiveness of β-lactams for empirical treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective cohort study
OBJECTIVES: Standard once-daily dosing of ceftriaxone may not lead to adequate antibiotic exposure in all cases of Staphylococcus aureus bacteraemia (SAB). Therefore, we compared clinical effectiveness of empirical antibiotic treatment with flucloxacillin, cefuroxime and ceftriaxone in adult patient...
Autores principales: | Buis, D T P, van der Vaart, T W, Prins, J M, van der Meer, J T M, Bonten, M J M, Sieswerda, E, van Werkhoven, C H, Sigaloff, K C E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154124/ https://www.ncbi.nlm.nih.gov/pubmed/36897327 http://dx.doi.org/10.1093/jac/dkad057 |
Ejemplares similares
-
Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteraemia (SAFE trial): protocol for a randomised, controlled, open-label, non-inferiority trial comparing 4 and 6 weeks of antibiotic treatment
por: Buis, DTP, et al.
Publicado: (2023) -
Correction to: Comparative effectiveness of β-lactams for empirical treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective cohort study
Publicado: (2023) -
Development of quality indicators for the management of Staphylococcus aureus bacteraemia
por: ten Oever, Jaap, et al.
Publicado: (2019) -
Current clinical practice in antibiotic treatment of Staphylococcus aureus bacteraemia: results from a survey in five European countries
por: Buis, D T P, et al.
Publicado: (2022) -
[18F]FDG-PET/CT in Staphylococcus aureus bacteremia: a systematic review
por: Buis, D. T. P., et al.
Publicado: (2022)